The effect of selenium enrichment on baker's yeast proteome

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 1018-1030

  El Bayoumy, Karam ^a   Das, Arunangshu ^a   Russell, Stephen ^b   Wolfe, Steven ^b   Jordan, Rick ^b   Renganathan, Kutralanathan ^b   Loughran, Thomas P ^a   Somiari, Richard ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Functional Genomics and Proteomics   (United States)

Author keywords

Baker's yeast; Cancer prevention; Proteomics; Pyruvate Kinase; Selenium

Indexed keywords

ELONGATION FACTOR 2; FUNGAL PROTEIN; HEAT SHOCK PROTEIN 70; INITIATION FACTOR 5A; PROTEIN ANTIBODY; PROTEOME; PYRUVATE KINASE; SELENIUM; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REGULAR YEAST; SACCHAROMYCES CEREVISIAE; SELENIUM ENRICHED YEAST; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES, NEOPLASM; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; PROTEOME; PROTEOMICS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SELENIUM; SOFTWARE;

EUKARYOTA;

EID: 84355166431     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.10.013     Document Type: Article

References (37)

1. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008, 67:253-256.
2. Syed D.N., Khan N., Afaq F., Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 2007, 16:2193-2203.
3. El-Bayoumy K., Sinha R. Molecular chemoprevention by selenium: a genomic approach. Mutat Res 2005, 591:224-236.
4. Nadiminty N., Gao A.C. Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol Nutr Food Res 2008, 52:1247-1260.
5. Jackson M.I., Combs G.F. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 2008, 11:718-726.
6. Karp D.D., Lee S.J., Shaw Wright G.L., Johnson D.H., Johnston M.R., Goodman G.E. A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non small cell lung cancer (NSCLC). J Clin Oncol 2010, 28:7s.
7. Duffield-Lillico A.J., Dalkin B.L., Reid M.E., Turnbull B.W., Slate E.H., Jacobs E.T., et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003, 91:608-612.
8. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
9. Kristal A.R. Are clinical trials the "gold standard" for cancer prevention research?. Cancer Epidemiol Biomarkers Prev 2008, 17:3289-3291.
10. El-Bayoumy K. The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis. Nutr Cancer 2009, 61:285-286.
11. Facompre N., El-Bayoumy K. Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res 2009, 69:2699-2703.
12. Algotar A.M., Stratton M.S., Xu M.J., Dalkin B.L., Nagle R.B., Hsu C.H., et al. Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer. Nutr Cancer 2011, 63:1-5.
13. Sabichi A.L., Lee J.J., Taylor R.J., Thompson I.M., Miles B.J., Tangen C.M., et al. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res 2006, 12:2178-2184.
14. Tastet L., Schaumloffel D., Lobinski R. ICP-MS-assisted proteomics approach to the identification of selenium-containing proteins in selenium-rich yeast. J Anal At Spectrom 2008, 23:309-317.
15. Díaz Huerta V., Hinojosa Reyes L., Marchante-Gayón J.M., Fernández Sánchez M.L., Sanz-Medel A. Total determination and quantitative speciation analysis of selenium in yeast and wheat flour by isotope dilution analysis ICP-MS. J Anal At Spectrom 2003, 18:1243-1247.
16. Dumont E., De Cremer K., Van Hulle M., Chery C.C., Vanhaecke F., Cornelis R. Identification of the major selenium compound, Se-Methionine, in three yeast (Saccharomyces cerevisiae) dietary supplements by on-line narrowbore liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 2005, 1071:191-196.
17. Toki N., Sumi H., Sasaki K., Boreisha I., Robbins K.C. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins. J Clin Invest 1985, 75:1212-1222.
18. Sherry S. Therapeutic fibinolysis: past, present and future. Thrombosis and urokinase 1977, 1-9. Academic Press, London, UK. R. Paoletti, S. Sherry (Eds.).
19. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
20. Boyiri T., Somiari R.I., Russell S., Aliaga C., El-Bayoumy K. Proteomics of rat prostate lobes treated with 2-N-hydroxylamino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 5alpha-dihydrotestosterone, individually and in combination. Int J Oncol 2009, 35:559-567.
21. Somiari R.I., Sullivan A., Russell S., Somiari S., Hu H., Jordan R., et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3:1863-1873.
22. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
23. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
24. Sprague G.F. Isolation and characterization of a Saccharomyces cerevisiae mutant deficient in pyruvate kinase activity. J Bacteriol 1977, 130:232-241.
25. Boles E., Schulte F., Miosga T., Freidel K., Schluter E., Zimmermann F.K., et al. Characterization of a glucose-repressed pyruvate kinase (Pyk2p) in Saccharomyces cerevisiae that is catalytically insensitive to fructose-1,6-bisphosphate. J Bacteriol 1997, 179:2987-2993.
26. Portela P., Howell S., Moreno S., Rossi S. In vivo and in vitro phosphorylation of two isoforms of yeast pyruvate kinase by protein kinase A. J Biol Chem 2002, 277:30477-30487.
27. Fraenkel D.G. The top genes: on the distance from transcript to function in yeast glycolysis. Curr Opin Microbiol 2003, 6:198-201.
28. Williams J.M., Chen G.C., Zhu L., Rest R.F. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth. Mol Microbiol 1998, 27:171-186.
29. Benjaphokee S, Koedrith P, Auesukaree C, Asvarak T, Sugiyama M, Kaneko Y, et al. CDC19 encoding pyruvate kinase is important for high-temperature tolerance in Saccharomyces cerevisiae. N Biotechnol in press.
30. Miksa M., Amin D., Wu R., Jacob A., Zhou M., Dong W., et al. Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response. Int J Mol Med 2008, 22:743-748.
31. Liu Z., Marquez M., Nilsson S., Holmberg A.R. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin. Oncol Rep 2009, 22:1451-1458.
32. Nakamura J., Aoyagi S., Nanchi I., Nakatsuka S., Hirata E., Shibata S., et al. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int J Oncol 2009, 34:1181-1189.
33. Cheng Y., Li H., Ren X., Niu T., Hait W.N., Yang J. Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS One 2010, 5:e9715.
34. Clement P.M., Henderson C.A., Jenkins Z.A., Smit-McBride Z., Wolff E.C., Hershey J.W., et al. Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem 2003, 270:4254-4263.
35. Schrauzer G.N. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr 2000, 130:1653-1656.
36. McSheehy S., Kelly J., Tessier L., Mester Z. Identification of selenomethionine in selenized yeast using two-dimensional liquid chromatography-mass spectrometry based proteomic analysis. Analyst 2005, 130:35-37.
37. Leibundgut M., Frick C., Thanbichler M., Bock A., Ban N. Selenocysteine tRNA-specific elongation factor SelB is a structural chimaera of elongation and initiation factors. EMBO J 2005, 24:11-22.